Amid an ongoing legal challenge against the United Kingdom’s lone gender clinic, The Tavistock and Portman NHS Foundation Trust, the National Health Service is now giving greater scrutiny to experimental puberty-blocking drugs prescribed to gender-confused children.
The NHS announced that it has examined the use of experimental hormone drugs in children who say they desire to undergo a medicalized gender transition. The findings of this official review, conducted by a former president of the Royal College of Paediatrics and Child Health and her team, will be published later this year, The Guardian reported Sunday. The National Institute for Health and Care Excellence (Nice) is also involved in the formal review and will advise Dr. Hilary Cass’ team.
“This is a fast-developing area of medicine with emerging evidence and high public interest. I look forward to chairing this independent group, bringing together medical and non-medical experts with a range of perspectives, to make evidence-based recommendations about the future use of these drugs,” Cass said.
She will lead a team of 20 experts.
The Tavistock clinic maintains their approach is “evidence-based” and that they work with each patient on a “case-by-case basis.” A clinic spokeswoman said they welcome the review.
The increased scrutiny of these practices is in part due to the testimony of Keira Bell, 23, who underwent a medical gender-transition during her teens and is a claimant in a lawsuit against the Tavistock clinic, brought by former NHS psychiatric nurse Sue Evans.
Bell, who is now known as what is called a “detransitioner” — someone who once lived and identified as the opposite sex but no longer does and in many cases regrets their transition — said in a statement last week that she does not believe minors are capable of giving informed consent to using experimental hormone drugs.
Click here to read more.
SOURCE: Christian Post, Brandon Showalter
BCNN1 WP 